372. Alvimopan

Nomenclature

CAS number: 156053-89-3
N-[(2S)-2-[[(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]glycine; [[2(S)-[[4(R)-(3-hydroxyphenyl)-3(R),4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]amino]acetic acid; ADL-8-2698; LY-246736; Entereg (Adolor).
C25H32N2O4; mol wt 424.53.
C 70.73%, H 7.60%, N 6.60%, O 15.07%.

Description and references

Peripheral mu-opioid receptor antagonist. Prepn: B. E. Cantrell et al., EP 506478; eidem, US 5250542 (1992, 1993 both to Lilly); D. M. Zimmerman et al., J. Med. Chem. 37, 2262 (1994). Improved synthesis: J. A. Werner et al., J. Org. Chem. 61, 587 (1996). Clinical pharmacology: S. S. Liu et al., Clin. Pharmacol. Ther. 68, 66 (2000). Clinical trial in postoperative ileus: A. Taguchi et al., N. Engl. J. Med. 345, 935 (2001); E. R. Viscusi et al., Surg. Endosc. 20, 64 (2006). Review of clinical experience: W. K. Schmidt, Am. J. Surg. 182, Suppl., 27S-38S (2001); and pharmacology: P. Neary, C. P. Delaney, Expert Opin. Invest. Drugs 14, 479-488 (2005).

Chemical structure

Derivative

Dihydrate.

Nomenclature

CAS number: 170098-38-1

Properties

Crystals, mp 210-213°. [α]D25 +51.8° (c = 1.0 in DMSO).

Therapeutic Category

Gastroprokinetic.

Keywords

Gastroprokinetic